Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster Logo McMaster logo

Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis

Authors:
McCallum, R. W.; Lembo, A.; Esfandyari, T.; Bhandari, B. R.; Ejskjaer, N.; Cosentino, C.; Helton, N.; Mondou, E.; Quinn, J.; Rousseau, F.; T. Z. P. Phase 2b Study Group
Journal:
Neurogastroenterology & Motility
Year:
2013
DOI